Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $23.0B | $22.8B | $23.7B | $23.4B | $25.4B | $26.0B | $26.3B | $28.2B | $33.4B | $36.8B |
| Revenue growth | — | -0.6% | 3.9% | -1.6% | 8.8% | 2.2% | 1.3% | 7.1% | 18.6% | 10.0% |
| Operating income | $9.79B | $9.97B | $10.3B | $9.67B | $9.14B | $7.64B | $9.57B | $7.90B | $7.26B | $9.08B |
| Operating margin | 42.6% | 43.6% | 43.2% | 41.4% | 35.9% | 29.4% | 36.3% | 28.0% | 21.7% | 24.7% |
| Net income | $7.72B | $1.98B | $8.39B | $7.84B | $7.26B | $5.89B | $6.55B | $6.72B | $4.09B | $7.71B |
| Net margin | 33.6% | 8.7% | 35.3% | 33.6% | 28.6% | 22.7% | 24.9% | 23.8% | 12.2% | 21.0% |
| EPS (diluted) | $10.24 | $2.69 | $12.62 | $12.88 | $12.31 | $10.28 | $12.11 | $12.49 | $7.56 | $14.23 |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $10.4B | $11.2B | $11.3B | $9.15B | $10.5B | $9.26B | $9.72B | $8.47B | $11.5B | $9.96B |
| Capital expenditures | $738M | $664M | $738M | $618M | $608M | $880M | $936M | $1.11B | $1.10B | $1.86B |
| Free cash flow | $9.62B | $10.5B | $10.6B | $8.53B | $9.89B | $8.38B | $8.79B | $7.36B | $10.4B | $8.10B |
| Share buybacks | $2.96B | $3.16B | $17.8B | $7.70B | $3.49B | $4.97B | $6.36B | $0.00 | $200M | $0.00 |
| Dividends paid | $3.00B | $3.37B | $3.51B | $3.51B | $3.75B | $4.01B | $4.20B | $4.56B | $4.83B | $5.12B |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $3.24B | $3.80B | $6.95B | $6.04B | $6.27B | $7.99B | $7.63B | $10.9B | $12.0B | $9.13B |
| Total assets | $77.6B | $80.0B | $66.4B | $59.7B | $62.9B | $61.2B | $65.1B | $97.2B | $91.8B | $90.6B |
| Long-term debt | $30.2B | $34.2B | $29.5B | $26.9B | $32.9B | $33.2B | $37.4B | $63.2B | $56.5B | $50.0B |
| Shareholders' equity | $29.9B | $25.2B | $12.5B | $9.67B | $9.41B | $6.70B | $3.66B | $6.23B | $5.88B | $8.66B |
| Retained earnings | -$438M | -$5.07B | -$18.0B | -$21.3B | -$21.4B | -$24.6B | -$28.6B | -$26.5B | -$27.6B | -$25.1B |
| Shares (wtd avg diluted) | 754M | 735M | 665M | 609M | 590M | 573M | 541M | 538M | 541M | 542M |
Every figure is extracted from AMGEN INC’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.